Similar articles

• EDITORIAL: Advances in Developing Versatile Tools for the Discovery of Novel Therapeutics.

  Hu Y. Hu Y. Curr Top Med Chem. 2017;17(20):2233-2234. doi: 10.2174/156802661720170707184419. Curr Top Med Chem. 2017. PMID: 28799501 No abstract available.
• Advancing the kinase field: new targets and second generation inhibitors.

  Laufer S, Bajorath J. Laufer S, et al. J Med Chem. 2015 Jan 8;58(1):1. doi: 10.1021/jm5018708. Epub 2014 Dec 9. J Med Chem. 2015. PMID: 25490234 No abstract available.
• Kinase inhibitor data modeling and de novo inhibitor design with fragment approaches.

  Vieth M, Erickson J, Wang J, Webster Y, Mader M, Higgs R, Watson I. Vieth M, et al. J Med Chem. 2009 Oct 22;52(20):6456-66. doi: 10.1021/jm901147e. J Med Chem. 2009. PMID: 19791746
• Small-Molecule Kinase Downregulators.

  Jones LH. Jones LH. Cell Chem Biol. 2018 Jan 18;25(1):30-35. doi: 10.1016/j.chembiol.2017.10.011. Epub 2017 Nov 22. Cell Chem Biol. 2018. PMID: 29174540 Review.
• Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors.

  Zheng J, Wu J, Ding X, Shen HC, Zou G. Zheng J, et al. Bioorg Med Chem Lett. 2021 Apr 15;38:127862. doi: 10.1016/j.bmcl.2021.127862. Epub 2021 Feb 18. Bioorg Med Chem Lett. 2021. PMID: 33609659 Review.